Charles G. Drake

3 ta ish

Johnson & Johnson (United States)

1. Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer

   Suzanne L. Topalian, F. Stephen Hodi, Julie R. Brahmer +27

   MaqolaOAOchiq kirish20123 iqtibos

   ABIABI:AkademIndex/2026.other.132162

2. LAG-3 Regulates Plasmacytoid Dendritic Cell Homeostasis

   Creg J. Workman, Yao Wang, Karim C. El Kasmi +4

   Maqola20093 iqtibos

   ABIABI:AkademIndex/2026.other.623674

3. FT555: Off-the-Shelf CAR-NK Cell Therapy Co-Targeting GPRC5D and CD38 for the Treatment of Multiple Myeloma

   John Reiser, Szeman Ruby Chan, Ketan Mathavan +16

   Maqola20222 iqtibos

   ABIABI:AkademIndex/2026.other.296918